Viatris Considers Sale of $3bn European OTC Assets

Viatris Considers Sale of $3bn European OTC Assets

Viatris is considering a potential sale of its consumer-health assets in Europe, in a deal that could fetch more than $3bn for the US drugmaker, according to people familiar with the matter. The Canonsburg, Pennsylvania-based company is working with investment bank...